Cidara Therapeutics, Inc. (CDTX)
Jan 7, 2026 - CDTX was delisted (reason: acquired by MRK)
221.38
+0.06 (0.03%)
Inactive · Last trade price on Jan 6, 2026
Cidara Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter | Current | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jan '26 Jan 5, 2026 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 | Jun '21 Jun 30, 2021 | Mar '21 Mar 31, 2021 |
| 6,974 | 2,809 | 1,132 | 263 | 294 | 76 | 55 | 84 | 72 | 85 | 102 | 114 | 55 | 45 | 34 | 57 | 82 | 111 | 100 | 128 | |
Market Cap Growth | 2270.27% | 3608.39% | 1974.59% | 213.32% | 309.03% | -11.06% | -46.51% | -26.59% | 31.21% | 90.53% | 201.52% | 98.89% | -33.05% | -59.78% | -66.18% | -55.25% | -7.27% | -11.23% | -35.50% | 27.70% |
Enterprise Value | 6,556 | 2,391 | 623.53 | 97.51 | 108 | -47.69 | -105.52 | 59.56 | 41.04 | 40.86 | 56.1 | 67.36 | 23.3 | -6.76 | 11.47 | 24.67 | 27.26 | 80.9 | 57.01 | 92.22 |
Last Close Price | 221.38 | 95.76 | 48.71 | 21.54 | 26.88 | 10.75 | 11.94 | 18.40 | 15.88 | 18.84 | 22.60 | 25.40 | 15.13 | 12.56 | 9.77 | 16.65 | 25.40 | 44.80 | 40.40 | 53.20 |
PS Ratio | - | - | - | 870.81 | 230.78 | 18.79 | 4.12 | 4.65 | 3.09 | 1.68 | 1.24 | 1.37 | 0.85 | 0.73 | 1.22 | 1.06 | 1.65 | 2.41 | 2.41 | 10.75 |
PB Ratio | 15.38 | 6.65 | 2.26 | 1.86 | 1.80 | 0.66 | 0.42 | -4.72 | -8.76 | 10.60 | 6.62 | 4.26 | -3.80 | 4.93 | -4.25 | 11.60 | 3.80 | -95.99 | 6.33 | 67.89 |
EV/Sales Ratio | - | - | - | 322.87 | 84.70 | -11.83 | -7.96 | 3.30 | 1.76 | 0.81 | 0.68 | 0.81 | 0.36 | -0.11 | 0.42 | 0.45 | 0.55 | 1.76 | 1.38 | 7.72 |
EV/EBITDA Ratio | - | - | - | - | - | 0.37 | 0.90 | - | - | - | - | - | - | 0.20 | - | - | - | - | - | - |
EV/EBIT Ratio | - | - | - | - | - | 0.37 | 0.90 | - | - | - | - | - | - | 0.20 | - | - | - | - | - | - |
EV/FCF Ratio | - | - | - | - | - | 0.30 | 0.84 | - | - | - | - | - | - | 0.30 | - | - | - | - | - | - |
Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.02 | 0.02 | 0.03 | 0.03 | -0.26 | -0.59 | 0.54 | 0.29 | 0.04 | -0.08 | 0.18 | -0.29 | 0.74 | 0.23 | -5.48 | 0.34 | 3.51 |
Debt / EBITDA Ratio | - | - | - | - | - | - | - | - | - | - | - | 0.36 | - | 0.11 | - | - | - | - | 0.49 | - |
Debt / FCF Ratio | - | - | - | - | - | - | - | - | - | - | 1.67 | - | - | 0.06 | - | - | - | - | 1.55 | - |
Asset Turnover | - | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.01 | 0.05 | 0.14 | 0.09 | 0.38 | 0.17 | 0.69 | 0.12 | 0.13 | 0.11 | 0.12 | 0.48 | 0.03 |
Quick Ratio | 4.40 | 4.40 | 15.86 | 3.48 | 3.86 | 2.91 | 4.21 | 0.55 | 0.74 | 1.45 | 1.78 | 2.07 | 0.93 | 1.76 | 0.94 | 1.41 | 1.91 | 1.21 | 1.52 | 1.07 |
Current Ratio | 4.62 | 4.62 | 16.45 | 3.87 | 4.25 | 3.54 | 4.25 | 0.72 | 0.90 | 1.62 | 1.98 | 2.23 | 1.09 | 1.93 | 1.16 | 1.62 | 2.11 | 1.41 | 1.80 | 1.28 |
Return on Equity (ROE) | -30.94% | -30.94% | -8.14% | -37.90% | -67.53% | -25.12% | -128.75% | -180.57% | 72.24% | -44.70% | -165.44% | 18.95% | -381.14% | 378.76% | -335.18% | -533.83% | -104.08% | -127.37% | 37.49% | -65.75% |
Return on Assets (ROA) | -26.03% | -26.03% | -7.74% | -20.67% | -38.45% | -15.41% | -79.54% | -12.71% | -15.21% | -6.80% | -12.64% | 4.06% | -22.41% | 25.28% | -25.40% | -33.35% | -24.71% | -31.40% | 15.71% | -26.35% |
Return on Invested Capital (ROIC) | 5118.57% | 5118.57% | 151.33% | 127.19% | 331.27% | 269.57% | 709.18% | 1581.85% | 84.59% | 113.11% | -747.20% | 30.08% | 238.68% | -771.41% | -2403.85% | 1240.98% | -474.94% | -682.92% | 223.41% | -780.22% |
Return on Capital Employed (ROCE) | -32.78% | -32.78% | -8.62% | -38.81% | -65.73% | -23.85% | -112.74% | -51.20% | -305.35% | -14.49% | -30.24% | 8.03% | -56.91% | 57.93% | -69.15% | -97.56% | -53.10% | -75.92% | 30.05% | -53.04% |
Buyback Yield / Dilution | -229.65% | -311.67% | -240.67% | -212.44% | -114.97% | -44.65% | -1.30% | 10.31% | -25.88% | -1.91% | -30.33% | -48.51% | -11.51% | -78.85% | -16.54% | -45.08% | -46.03% | -14.64% | -44.31% | -16.87% |
Total Shareholder Return | -229.65% | -311.67% | -240.67% | -212.44% | -114.97% | -44.65% | -1.30% | 10.31% | -25.88% | -1.91% | -30.33% | -48.51% | -11.51% | -78.85% | -16.54% | -45.08% | -46.03% | -14.64% | -44.31% | -16.87% |